• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Elekta announces a new CEO

Elekta announces a new CEO

June 9, 2025 By Chris Newmarker

This is a portrait photo of incoming Elekta CEO Jakob Just-Bomholt.
Jakob Just-Bomholt, incoming CEO of Elekta [Image courtesy of the company]

Swedish precision radiation therapy devices and software maker Elekta is bringing in an executive from Denmark to be its new CEO.

Elekta today announced the appointment of Jakob Just-Bomholt, who will take over the corner office at the company on Sept. 1, 2025. Just-Bomholt, a Danish citizen, will be based in Stockholm and will start onboarding at Elekta in office, working with current acting CEO Jonas Bolander and the rest of the management team.

Just-Bomholt most recently was CEO of 3Shape, a Danish global innovator in 3D scanning and CAD/CAM software for the dental industry. Before that, he was a senior executive within Falck A/S and A/P Moller Maersk.

“His strategic leadership and international experience, combined with a proven ability to drive profitable growth and global expansion through customer-focused innovation and operational excellence, make him very well-suited to lead Elekta forward. The board is confident in Jakob’s ability to guide the company into its next chapter and deliver value to our shareholders, customers, and the cancer patients we serve around the world,” Laurent Leksell, Elekta’s founder and board chair, said in a news release.

Just-Bomholt said: “I am honored to join Elekta, a company with a proud legacy and a powerful mission to improve the lives of people with cancer. Radiation therapy plays a vital role in modern oncology, and I look forward to working with the talented team at Elekta to continue delivering life-changing solutions to patients around the world. Elekta holds a strong market position, industry leading product portfolio, and considerable growth potential. I look forward to guiding the company in delivering long-term value for all our stakeholders.”

Elekta’s previous CEO, Gustaf Salford stepped down in February after the company’s board advised that it was time for new leadership. Leskell said at the time that the company needed a more intense focus on improving profitability and strengthening growth.

Headquartered in Stockholm, Elekta ranked 56th for annual revenue in our most recent Medtech Big 100 report on the world’s largest medical device companies.

Filed Under: Business/Financial News, Featured, Imaging, Oncology, Radiosurgery/Radiation therapy Tagged With: Elekta, Personnel Moves

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy